{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T06:54:43Z","timestamp":1761893683952},"reference-count":4,"publisher":"American Society of Hematology","issue":"8","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2001,4,15]]},"DOI":"10.1182\/blood.v97.8.2527","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T12:46:47Z","timestamp":1027774007000},"page":"2527-2528","update-policy":"http:\/\/dx.doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":7,"title":["Development of a myeloproliferative disorder in a patient with monoclonal gammopathy of undetermined significance secreting immunoglobulin of the M class and treated with thalidomide and anti-CD20 monoclonal antibody"],"prefix":"10.1182","volume":"97","author":[{"given":"Maria-Christina","family":"Kyrtsonis","sequence":"first","affiliation":[{"name":"Hematology Section National and Kapodistrian University of Athens School of Medicine Laikon General Hospital Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Styliani I.","family":"Kokoris","sequence":"additional","affiliation":[{"name":"Hematology Section National and Kapodistrian University of Athens School of Medicine Laikon General Hospital Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flora N.","family":"Kontopidou","sequence":"additional","affiliation":[{"name":"Hematology Section National and Kapodistrian University of Athens School of Medicine Laikon General Hospital Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina P.","family":"Siakantaris","sequence":"additional","affiliation":[{"name":"Hematology Section National and Kapodistrian University of Athens School of Medicine Laikon General Hospital Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos","family":"Kittas","sequence":"additional","affiliation":[{"name":"Hematology Section National and Kapodistrian University of Athens School of Medicine Laikon General Hospital Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerassimos A.","family":"Pangalis","sequence":"additional","affiliation":[{"name":"Hematology Section National and Kapodistrian University of Athens School of Medicine Laikon General Hospital Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2020021216544372900_B1","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1182\/blood.V96.12.4007","article-title":"Serious myeloproliferative reactions associated with the use of thalidomide in myelofibrosis with myeloid metaplasia [letter].","volume":"96","author":"Tefferi","year":"2000","journal-title":"Blood."},{"key":"2020021216544372900_B2","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJM199911183412102","article-title":"Antitumor activity of thalidomide in refractory multiple myeloma.","volume":"341","author":"Singhal","year":"1999","journal-title":"N Engl J Med."},{"key":"2020021216544372900_B3","first-page":"5022a","article-title":"Thalidomide is an effective agent for patients with primary amyloidosis [abstract].","volume":"96","author":"Vescio","year":"2000","journal-title":"Blood."},{"key":"2020021216544372900_B4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0037-1963(00)90080-5","article-title":"Pilot studies of thalidomide in acute myelogenous leukemia, myelodysplastic syndromes and myeloproliferative disorders.","volume":"37(suppl 3)","author":"Thomas","year":"2000","journal-title":"Semin Hematol."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/97\/8\/2527\/1672743\/h8080102524c.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/97\/8\/2527\/1672743\/h8080102524c.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T22:25:33Z","timestamp":1581546333000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/97\/8\/2527\/53160\/Development-of-a-myeloproliferative-disorder-in-a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,4,15]]},"references-count":4,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2001,4,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.v97.8.2527","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2001,4,15]]}}}